"We're disappointed that the FDA has chosen to all but eliminate the option of having printed information for prescription drugs available to healthcare professionals. E-labeling should not totally replace paper inserts. A July 2013 GAO report concluded that relying exclusively on electronic labeling could disadvantage physicians, pharmacists, other healthcare providers, and ultimately patients, potentially adversely impacting public health. Furthermore, FDA's proposal goes against congressional intent, which was most recently made clear in the House and Senate-passed funding bill.
"We appreciate Senators Mark Pryor (D-AR), Susan Collins (R-ME), and Lamar Alexander (R-TN) for their leadership on this issue, and we will continue to work with Congress, FDA, and other stakeholders to ensure that Americans who are affected by the availability of this information are not disadvantaged by such a move."
The American Forest & Paper Association (AF&PA) serves to advance a sustainable U.S. pulp, paper, packaging, and wood products manufacturing industry through fact-based public policy and marketplace advocacy. AF&PA member companies make products essential for everyday life from renewable and recyclable resources and are committed to continuous improvement through the industry's sustainability initiative - Better Practices, Better Planet 2020. The forest products industry accounts for approximately 4 percent of the total U.S. manufacturing GDP, manufactures approximately $210 billion in products annually, and employs nearly 900,000 men and women. The industry meets a payroll of approximately $50 billion annually and is among the top 10 manufacturing sector employers in 47 states.